The implication of adenosine receptor expression in prediction of methotrexate clinical response in Egyptian rheumatoid arthritis patients
Abstract Background Adenosine signaling is now an accepted explanation for the therapeutic mechanism of Methotrexate (MTX) in rheumatoid arthritis (RA). Adenosine receptors categorized into four subclasses: adenosine A1 receptor (ADORA1), adenosine 2a receptor (ADORA2a), adenosine 2b receptor (ADORA...
Main Authors: | Nivine Fathi Darwish, Samar Abd Alhamed Tabra, Nivin Naeem Baiomy, Heba A. Mahmoud, Reham A. Mariah, Shymaa Ahmed Hablas |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-02-01
|
Series: | Egyptian Rheumatology and Rehabilitation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43166-021-00107-9 |
Similar Items
-
Non-persistence and non-adherence to MTX therapy in patients with rheumatoid arthritis: a retrospective cohort study based on German RA patients
by: Müller S, et al.
Published: (2017-07-01) -
Methotrexate‐associated proliferative disorder in the lower esophagus extending to the gastroesophageal junction: A case report
by: Yuki Hojo, et al.
Published: (2022-04-01) -
Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
by: Jeiziner C, et al.
Published: (2022-05-01) -
Mechanistic role of quercetin as inhibitor for adenosine deaminase enzyme in rheumatoid arthritis: systematic review
by: Amira Atta, et al.
Published: (2024-01-01) -
Relapsed isolated CNS lymphoma treated with radiotherapy and intrathecal methotrexate followed by high‐dose intravenous methotrexate, rituximab, and temozolomide: A case report
by: Ikhwan Rinaldi, et al.
Published: (2024-03-01)